Leveraging on past investment in understanding the immunology of COVID-19 – the South African experience

• Thandeka Moyo-Gwete,
• Penny L. Moore

Affiliations

Thandeka Moyo-Gwete

1.National Institute for Communicable Diseases (NICD), National Health Laboratory Service (NHLS), Johannesburg, South Africa; 2.SAMRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Penny L. Moore

1.National Institute for Communicable Diseases (NICD), National Health Laboratory Service (NHLS), Johannesburg, South Africa; 2.SAMRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; 3.Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; 4.Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa